提示：

1、投稿方式：在线投稿。

2、期刊网址：

https://www.futuremedicine.com/journal/imt

3、投稿网址：

https://mc04.manuscriptcentral.com/fm-imt

4、官网邮箱：r.gilroy@futuremedicine.com

5、期刊刊期：一年出版18期。

2021年8月17日星期二

期刊信息【官网信息】

Immunotherapy

Aims & Scope

The field of immunotherapy is moving forward at an unprecedented rate, and a range of therapeutic approaches are now used in clinical practice, often with outstanding success. Cancer immunotherapies are coming of age and have the potential to produce long-lasting remission, often with fewer side effects and reduced drug resistance compared with conventional therapies. Recently the FDA has approved immunotherapies for melanoma and lung cancer, and clinical trials are yielding positive results for a range of cancer types, reflecting the promising new role for immunotherapy in cancer treatment. Immunotherapies are also being applied in a variety of other disease areas, including allergy, rheumatoid disease, autoimmunity and transplantation, as well as in many infections, such as HIV and hepatitis.

Many aspects of the immune system and mechanisms of immunomodulatory therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. The journal Immunotherapy offers the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field.

Articles published in Immunotherapy include key areas such as:

Cancer immunotherapy, including checkpoint blockade, cancer vaccines, adoptive T cell therapy, monoclonal antibodies and cytokines

Combined chemo/radio immunotherapy in cancer treatment

Biomarkers for personalized cancer immunotherapy

Allergen immunotherapy, including sublingual, subcutaneous and oral immunotherapy

Restorative immunotherapy for HIV and other immunocompromised patients

Suppressive immunotherapy for autoimmunity diseases and transplantation

Basic science of immunotherapeutic approaches 

Drug–immune system interactions

Drug delivery systems, drug combinations and drug–drug interactions

Summaries evaluating newly approved immunotherapeutic agents

Newly identified immune targets of drugs

Results of recent findings and clinical trials relevant to the field of immunotherapy

Post marketing research, including adverse events, drug safety, pharmacoeconomics, cost–benefit issues, real-world evidence and outcomes research

Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.